Composition
- Active ingredients
- DOLUTEGRAVIR AND LAMIVUDINE 300MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA219623.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Dolutegravir and Lamivudine
- Dosage form
- Tablet
- Applicant
- Emcure Pharms LTD
- Status
- Tentative approval
- FDA approval
- 12 Jun 2025
- Application
- ANDA219623-002